✦ LIBER ✦

59 Validation of Therapeutic Targets in K-Ras Driven Lung and Pancreatic Tumors

✍ Scribed by M. Barbacid

Book ID: 117662601
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 65 KB
Volume: 48
Category: Article
ISSN: 0959-8049
DOI: 10.1016/s0959-8049(12)70763-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

191: Heterogeneity among early-stage K-R

191: Heterogeneity among early-stage K-Ras driven lung adenocarcinoma predicts tumor aggressiveness and identifies Ddr1 as a therapeutic target

✍ Ambrogio, C.; Gomez, G.; Santamaria, D.; Barbacid, M. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 76 KB

Role of autophagy in K-RAS- and B-RAF-dr

Role of autophagy in K-RAS- and B-RAF-driven lung cancers

✍ White, Eileen 📂 Article 📅 2014 🏛 BioMed Central 🌐 English ⚖ 88 KB

Targeting filamin A reduces K-RAS–induce

Targeting filamin A reduces K-RAS–induced lung adenocarcinomas and endothelial response to tumor growth in mice

✍ Rajesh K Nallapalli, Mohamed X Ibrahim, Alex X Zhou, Sashidar Bandaru, Sai Nares 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 718 KB

Vascular targeting by EndoTAG™-1 enhance

Vascular targeting by EndoTAG™-1 enhances therapeutic efficacy of conventional chemotherapy in lung and pancreatic cancer

✍ Martin E. Eichhorn; Ivan Ischenko; Siiri Luedemann; Sebastian Strieth; Armine Pa 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 1001 KB

## Abstract Cationic lipid complexed paclitaxel (EndoTAG™‐1) is a novel vascular targeting agent for the treatment of cancer. Here, the aim was to investigate intratumoral drug distribution after EndoTAG™‐1 therapy and analyze the impact of EndoTAG™‐1 scheduling on antitumoral efficacy. The therape

The role of K-Ras gene mutation in TRAIL

The role of K-Ras gene mutation in TRAIL-induced apoptosis in pancreatic and lung cancer cell lines

✍ Ravi P. Sahu; Sanjay Batra; Prabodh K. Kandala; Thomas L. Brown; Sanjay K. Sriva 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 420 KB

Downregulation of PAR-4, a pro-apoptotic

Downregulation of PAR-4, a pro-apoptotic gene, in pancreatic tumors harboring K-ras mutation

✍ Mansoor M. Ahmed; David Sheldon; Mushtaq A. Fruitwala; Kolaparthi Venkatasubbara 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 363 KB

## Abstract Oncogenic ras is known to inhibit cell death and growth inhibitory genes and activate prosurvival genes. Proapoptotic gene PAR‐4, has been found to be downregulated by oncogenic ras. Since pancreatic tumors harbor a high incidence of __K‐ras__ point mutations, we hypothesized that oncog